Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin

被引：0

|

作者：

Martin, Silas C.

Henk, Henry J.

Chow, Wing

机构：

来源：

DIABETES | 2014年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1181-P

引用

收藏

页码：A307 / A307

页数：1

相关论文

共 50 条

[1] ACHIEVEMENT OF GLYCAEMIC TARGETS WITH CANAGLIFLOZIN IN TRIPLE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
Diels, J.
Schubert, A.
Hamilton, G.
Canovatchel, W.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A598 - A598
[2] The platelets characteristics in type 2 diabetes mellitus (T2DM)
Buryachkovskaya, L.
Uchitel, I. A.
Sumarokov, A. B.
Docenko, U., V
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
[3] CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PEOPLE WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING CANAGLIFLOZIN FROM A UNITED STATES MANAGED CARE SAMPLE
Martin, S.
Henk, H.
Chow, W.
[J]. VALUE IN HEALTH, 2014, 17 (03) : A261 - A261
[4] Blood Pressure (BP) Effects of Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)
Pfeifer, Michael
Townsend, Raymond
Davies, Michael J.
Vijapurkar, Ujjwala
Ren, Jimmy
[J]. DIABETES, 2016, 65 : A303 - A303
[5] Achievement of Diabetes-related Treatment Goals with Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)
Blonde, Lawrence
Woo, Vincent
Mathieu, Chantal
Yee, Jacqueline
Vijapurkar, Ujjwala
Meininger, Gary
[J]. DIABETES, 2014, 63 : A284 - A284
[6] Genital Mycotic Infections With Canagliflozin (CANA) in Subjects With Type 2 Diabetes Mellitus (T2DM)
Nyirjesy, Paul
Sobel, Jack
Fung, Albert
Gassmann-Mayer, Cristiana
Ways, Kirk
Usiskin, Keith
[J]. DIABETES, 2013, 62 : A276 - A276
[7] Pharmacokinetics (PK) and Pharmacodynamics (PD) of Canagliflozin (CANA) in Pediatric Patients with Type 2 Diabetes Mellitus (T2DM)
Tamborlane, William
Polidori, David
Di Prospero, Nicolas
[J]. DIABETES, 2017, 66 : A371 - A371
[8] Effect of Canagliflozin (CANA) on Liver Function Tests (LFTs) in Patients with Type 2 Diabetes Mellitus (T2DM)
Usiskin, Keith
Leiter, Lawrence A.
Forst, Thomas
Polidori, David
Xie, John
Sha, Sue
[J]. DIABETES, 2014, 63 : A284 - A284
[9] Canagliflozin (CANA) Reduces Serum Uric Acid (SUA) in Patients with Type 2 Diabetes Mellitus (T2DM)
Davies, Michael
Trujillo, Angelina
Vijapurkar, Ujjwala
Damara-Ju, C. V.
Meininger, Gary
[J]. DIABETES, 2014, 63 : A283 - A284
[10] Consistent Effects of Canagliflozin (CANA) Across Racial Subgroups of Patients with Type 2 Diabetes Mellitus (T2DM)
Gavin, James R., III
Davies, Melanie J.
Davies, Michael
Vija-Purkar, Ujjwala
Alba, Maria
[J]. DIABETES, 2014, 63 : A285 - A285

← 1 2 3 4 5 →